[1] Alastruey-Izquierdo A, Mellado E, Peláez T, et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP study)[J]. Antimicrob Agents Chemother, 2013,57(7):3380-3387.
[2] Slavin M, van Hal S, Sorrell TC, et al. Invasive infections due to filamentous fungi other than Aspergillus:epidemiology and determinants of mortality[J]. Clin Microbiol Infect, 2015,21(5):490-491.
[3] Li FG, Yang YP, Li W, et al. Spontaneous remission of subcutaneous scedosporiosis caused by Scedosporium dehoogii in a psoriatic patient[J]. Mycopathologia, 2017,182(5/6):561-567.
[4] 李娟娟, 黎铧, 胡竹林. 眼外伤所致尖端赛多孢菌性眼内炎[J]. 中华眼外伤职业眼病杂志, 2011,33(3):161-162.
[5] 王光超, 马圣清, 王家璧, 等. 皮肤病及性病学[M]. 第1版. 北京:科学出版社, 2002.
[6] Troke P, Aguirrebengoa K, Arteaga C, et al. Treatment of scedosporiosis with voriconazole:clinical experience with 107 patients[J]. Antimicrob Agents Chemother, 2008,52(5):1743-1750.
[7] Wang H, Wan Z, Li R, et al. Molecular identification and susceptibility of clinically relevant Scedosporium spp. in China[J]. Biomed Res Int,2015,2015:109656.
[8] He XH, Wu JY, Wu CJ, et al. Scedosporium apiospermum infection after near-drowning[J]. Chin Med J (Engl), 2015,128(15):2119-2123.
[9] William JS, Wiley AS, Jackie LM, et al. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide[J]. Clin Microbiol, 2003,41(8):3981-3985.
[10] 魏兵, 李春盛. 6例淹溺合并真菌感染患者的救治[J]. 中华急诊医学杂志, 2011,20(5):541-544.
[11] 常晶, 栗方, 刘敏, 等. 浅谈尖端赛多孢子菌引起的侵袭性真菌感染[J]. 中国真菌学杂志, 2008,3(6):364-367.
[12] 张靖东, 龚启荣, 管怀进. 匹马霉素联合酮康唑治疗真菌性角膜溃疡[J]. 苏州医学院学报, 1997(2):300-301.
[13] Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases[J]. Med Mycol, 2009,47(4):359-370.
[14] Cimon B, Carrere J, Vinatier JF, et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis[J]. Eur J Clin Microbiol Infect Dis, 2000,19(1):53-56.
[15] Defontaine A, Zouhair R, Cimon B, et al. Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis[J]. J Clin Microbiol, 2002,40(6):2108-2114.
[16] Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients[J]. Transpl Infect Dis, 2014,16(4):578-587.
[17] Oliveira FM, Unis G, Hochhegger B, et al. Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole:report of a case and review of the Brazilian reports on scedosporiosis[J]. Rev Inst Med Trop Sao Paulo, 2013,55(2):121-123.
[18] Yu Z, Hu L, Jiang M, et al. Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation[J]. Intern Med, 2013,52(6):689-693.
[19] Katragkou A, Dotis J, Kotsiou M, et al. Scedosporium apiospermum infection after neardrowning[J]. Mycoses, 2007,50(5):412-421.
[20] 帕丽达·阿布利孜, Yaguchi Takashi, 罗德梅, 等. 多育赛多孢菌性鼻窦炎1例——致病菌的鉴定和体外抗真菌药物敏感性研究[J]. 中国真菌学杂志, 2010,5(1):1-4.
[21] Salehi E, Hedayati MT, Zoll J, et al. Discrimination of aspergillosis, mucormycosis, fusariosis, and scedosporiosis in formalin-fixed paraffin-embedded tissue specimens by use of multiple real-time quantitative PCR assays[J]. J Clin Microbiol, 2016,54(11):2798-2803.[22] Mina, Sara, Marot-Leblond, et al. Purification and characterization of a mycelial catalase from Scedosporium boydii, a useful tool for specific antibody detection in patients with cystic fibrosis[J]. Clin Vaccine Immunol, 2015,22(1):37-45.[23] Chen M, Zeng J, De Hoog GS, et al. The ‘species complex’ issue in clinically relevant fungi:a case study in Scedosporium apiospermum[J]. Fungal Biol, 2016,120(2):137-146.[24] 曾敬思, 李宏杰, 毛叶红, 等. 继发型肺结核患者下呼吸道内赛多孢子菌定植初探[J]. 中国真菌学杂志, 2017,12(2):89-91.[25] de Hoog GS, MarvinSikkema FD, Lahpoor GA, et al. Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolifcans[J]. Mycoses, 1994,37(3-4):71-80.[26] Tintelnot K, Just-Nubling G, Horre R, et al. A review of German Scedosporium prolificans cases from 1993 to 2007[J]. Med Mycol, 2009,47(4):351-358.[27] Thomas PA, Kaliamurthy J. Mycotic keratitis:epidemiology, diagnosis and management[J]. Clin Microbiol Infect, 2013,19(3):210-220.[J].[28] Holle J, Leichsenring M, Meissner PE. Nebulized voriconazole in infections with Scedosporium apiospermum-case report and review of the literature[J]. J Cyst Fibros, 2014,13(4):400-402.